The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Oscar Health's targets of a 20% revenue CAGR through 2027 and 5% operating margin imply operating income around $700m in 3 ...

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

Abby Jones' first stop of the day delivering medication was the home of 90-year-old Sarah Campbell Kier. "Come in!" yelled Kier. Jones didn't have to knock. Kier had the screen door open and was ...

Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...

The lawsuit consolidates 27 cases against MultiPlan and large insurers alleging the companies conspired to depress rates for ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

A roundup of the most newsworthy healthcare announcements from PR Newswire this week, including the FDA's nicotine reduction ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.